Dec 14, 2017 16:30
JST
- This collaboration creates the world's first clinically reliable and robust patient-specific diagnostic and predictive platform to improve treatment of liver cancer.
- The platform will provide high throughput genomics and drug screening data from a patient's liver cancer sample, to inform timely clinical management.
- The high throughput data will significantly enhance and direct drug development for liver cancer.
- This multi-institutional effort brings together leading experts in translational research in liver cancer from Singapore and the Republic of Korea.